These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9869321)

  • 1. Normal and pathological aging--findings of positron-emission-tomography.
    Mielke R; Kessler J; Szelies B; Herholz K; Wienhard K; Heiss WD
    J Neural Transm (Vienna); 1998; 105(8-9):821-37. PubMed ID: 9869321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography in myotonic dystrophy.
    Mielke R; Herholz K; Fink G; Ritter D; Heiss WD
    Psychiatry Res; 1993 Jun; 50(2):93-9. PubMed ID: 8378492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
    Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
    J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of Alzheimer's disease with PET.
    Salmon E; Sadzot B; Maquet P; Degueldre C; Lemaire C; Rigo P; Comar D; Franck G
    J Nucl Med; 1994 Mar; 35(3):391-8. PubMed ID: 8113882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R; Heiss WD
    J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral and cardiovascular aging and brain energy metabolism. Studies with positron-emission tomography in man].
    Baron JC; Marchal G
    Presse Med; 1992 Jul; 21(26):1231-7. PubMed ID: 1409478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging.
    Fazekas F; Alavi A; Chawluk JB; Zimmerman RA; Hackney D; Bilaniuk L; Rosen M; Alves WM; Hurtig HI; Jamieson DG
    J Nucl Med; 1989 Oct; 30(10):1607-15. PubMed ID: 2795200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
    Garraux G; Salmon E; Degueldre C; Lemaire C; Laureys S; Franck G
    Neuroimage; 1999 Aug; 10(2):149-62. PubMed ID: 10417247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients.
    Blin J; Ivanoiu A; Coppens A; De Volder A; Labar D; Michel C; Laterre EC
    Neuroimage; 1997 Nov; 6(4):335-43. PubMed ID: 9417975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.
    Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative EEG mapping and PET in Alzheimer's disease.
    Szelies B; Grond M; Herholz K; Kessler J; Wullen T; Heiss WD
    J Neurol Sci; 1992 Jul; 110(1-2):46-56. PubMed ID: 1506868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
    Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
    N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review.
    Rapoport SI
    Cerebrovasc Brain Metab Rev; 1991; 3(4):297-335. PubMed ID: 1772739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
    Salmon E; Franck G
    Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.